Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Nephrologie|November 9, 2000
[Severe Schonlein-Henoch nephritis in adults. A report of twenty cases]F Schillinger, P S Denis, J J Dion, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 22, 2015
A one-year survey of Microsporum audouinii infections in Belgium: epidemiological and genotypic characterizationR Sacheli, C Adjetey, R Darfouf, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 25, 2001
Comparative effects of the novel vasotocin analogue F-180 vs. vasopressin and terlipressin on systemic and splanchnic isolated vessels from portal hypertensive ratsM C Ramírez, M A Martínez-Cuesta, P D'Ocon, et al.
Acta Clinica Belgica|January 1, 1989
In vitro activity of amoxycillin plus clavulanic acid and ticarcillin plus clavulanic acid compared with that of other antibiotics against anaerobic bacteriaD Pierard, A De Meyer, P Rosseel, et al.
Epidemiology and Infection|October 1, 2013
Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years, 2012K Huygen, C Rodeghiero, D Govaerts, et al.
Computational Intelligence and Neuroscience|July 21, 2016
Quadrupedal Robot Locomotion: A Biologically Inspired Approach and Its Hardware ImplementationA Espinal, H Rostro-Gonzalez, M Carpio, et al.
Revue Medicale De Liege|November 19, 2020
[The COVID-19 breaker : PCR to the rescue !]M P Hayette, C Meex, S Bontems, et al.
Epidemiology and Infection|April 9, 2005
Management of chronic hepatitis C in French departments of internal medicine and infectious diseasesP Cacoub, I Goderel, P Morlat, et al.
Acta Clinica Belgica|January 1, 1996
In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 surveyD Pierard, A De Meyer, P Rosseel, et al.
The European Respiratory Journal|January 30, 2010
Identification of a novel water-soluble activator of wild-type and F508del CFTR: GPact-11aJ Bertrand, B Boucherle, A Billet, et al.
Pageof 12